
Blog|Articles|May 13, 2010
- Psychiatric Times Vol 27 No 5
- Volume 27
- Issue 5
A Psychiatrist’s Guitar Poem
Author(s)Richard M. Berlin, MD
Hear the story of wood...
Advertisement
Hear the story of wood,
cut and stained
and carved for someone’s need.
Caress the smooth neck
a palm can praise.
Smell mahogany
shaved and steamed,
fragrant as cinnamon.
Rake, slide, bend
tense strings,
make them breathe
each note.
Follow silver steel
over the bridge
from body to head,
each cord vibrating
when skilled hands
and callused fingertips
pick sweet equations
where practice becomes song.
Listen for a minor key,
all the patience and flesh
in the finish,
like a man
in my office
composing a life.
Articles in this issue
over 16 years ago
Get the Bigger Therapeutic Pictureover 16 years ago
Ethical Aspects of Self-Disclosure in Psychotherapyover 16 years ago
Introduction: Ethical Dilemmas Old and Newover 16 years ago
Undue Pharmaceutical Influence on Psychiatric Practiceover 16 years ago
DSM5 and the Medicalization of Grief: Two Perspectivesover 16 years ago
Extraordinarily Ordinaryover 16 years ago
The Political Diagnosis: Psychiatry in the Service of the Lawover 16 years ago
The Fort Hood Aftermath-Army Accountability Review and Psychiatristsover 16 years ago
Memory Reconsolidation and What Albert Ellis Knew All AlongAdvertisement
Related to this article

Real-world data show TRD costs spike during resistant episodes; Compass’ psilocybin COMP360 delivers durable symptom relief through 26 weeks, potentially easing resource strain.

Antipsychotic levels clarify adherence, guide dose escalation up to a point of futility, and offer more than pharmacogenetic testing, says Jonathan Meyer, MD.

Learn how clinicians tailor antidepressants by diagnosis, symptoms, adverse effects, and next-step strategies for treatment-resistant depression.

How to interpret antipsychotic drug levels in schizophrenia: when labs mislead, when levels help adherence and toxicity checks, and why serial monitoring matters.

Male athletes with anorexia often go unnoticed as “discipline”; learn red flags, sport-specific risks, health consequences, and treatment steps for earlier diagnosis.

Explore major depression subtypes—from melancholic to inflammatory—and how they shape symptoms, biology, and treatment choices for better outcomes.

Therapeutic drug monitoring takes guesswork out of antipsychotic care—spotting nonadherence, guiding dose targets, and defining response thresholds and the “point of futility” in schizophrenia.
Advertisement
Advertisement
Trending on Psychiatric Times
1
How Best to Manage Treatment-Resistant Depression
2
Antipsychotic Plasma Levels in Schizophrenia: Detecting Nonadherence and Guiding Dose Decisions
3
Can Durable Response to Psilocybin Reshape Treatment-Resistant Depression Care?
4
Podcast: Using Antipsychotic Plasma Levels to Guide Schizophrenia Treatment With Jonathan M. Meyer, MD
5

